Daily pill aims to stop dangerous swelling attacks
NCT ID NCT06679881
Summary
This study is testing a long-term, daily oral tablet called deucrictibant to see if it can safely prevent the sudden, severe swelling attacks caused by hereditary angioedema (HAE). It will involve about 170 adolescents and adults with HAE who will take the pill once a day for over two years. The main goals are to check the drug's safety and see how well it reduces the number and severity of attacks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA (HAE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Study Site
RECRUITINGSanta Monica, California, 90404, United States
-
Study Site
RECRUITINGWalnut Creek, California, 94598, United States
-
Study Site
RECRUITINGSt Louis, Missouri, 63141, United States
-
Study Site
RECRUITINGMelbourne, 3052, Australia
-
Study Site
RECRUITINGMelbourne, Australia
-
Study Site
RECRUITINGPerth, Australia
-
Study Site
RECRUITINGVienna, Austria
-
Study Site
RECRUITINGSofia, Bulgaria
-
Study Site
RECRUITINGMontreal, Canada
-
Study Site
RECRUITINGBerlin, Germany
-
Study Site
RECRUITINGFrankfurt, Germany
-
Study Site
RECRUITINGHong Kong, Hong Kong
-
Study Site
RECRUITINGDublin, Ireland
-
Study Site
RECRUITINGPadua, Italy
-
Study Site
RECRUITINGKrakow, Poland
-
Study Site
RECRUITINGCape Town, South Africa
-
Study Site
RECRUITINGDaegu, South Korea
-
Study Site
RECRUITINGSeoul, South Korea
-
Study Site
RECRUITINGBarcelona, 08907, Spain
-
Study Site
RECRUITINGBrighton, United Kingdom
-
Study Site
RECRUITINGBristol, United Kingdom
-
Study Site
RECRUITINGCambridge, United Kingdom
-
Study Site
RECRUITINGLondon, United Kingdom
-
Study Site
RECRUITINGPlymouth, United Kingdom
Conditions
Explore the condition pages connected to this study.